Grifols Net Interest Income Quarterly:
-72.95M for March 31, 2013Grifols Historical Net Interest Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -72.95M |
| Dec. 31, 2012 | -50.43M |
| Sept. 30, 2012 | -93.03M |
| June 30, 2012 | -85.82M |
| March 31, 2012 | -105.22M |
| Dec. 31, 2011 | -67.28M |
| Sept. 30, 2011 | -90.63M |
| June 30, 2011 | -58.65M |
| March 31, 2011 | -18.25M |
| Dec. 31, 2010 | 5.681M |
| Sept. 30, 2010 | -22.54M |
| Dec. 31, 2009 | -19.20M |
About Interest Income
Revenues from interest-bearing assets. A typical example would be interest earned by a bank on personal or commercial loans.
Learn More
GRFS Net Interest Income Quarterly Benchmarks
| Companies | |
|---|---|
| Cadence Pharmaceuticals | -1.078M |
| ARCA biopharma | -0.001M |
| Sangamo BioSciences |
GRFS Net Interest Income Quarterly Rankings
| Overall |
39th percentile 4815 of 8005 |
| Sector |
16th percentile 573 of 686 in Healthcare |
| Industry |
17th percentile 204 of 248 in Biotechnology |
GRFS Net Interest Income Quarterly Range, Past 5 Years
| Minimum | -105.22M | Mar 2012 |
| Maximum | 5.681M | Dec 2010 |
| Average | -56.53M |
